UFC Fighters Allowed to Use CBD in 2018
As of now, CBD products are categorized under the 2017 WADA (World Anti-Doping Agency) prohibited list. But in 2018, this looks to change. Next year, CBD will no longer be prohibited by the WADA, and can be utilized by all fighters. This means that these professional athletes can no longer be punished for CBD being found in their pre-match test results. Where before, fighters could be suspended for utilizing these products, as of 2018 this will no longer be the case.
Products such as CBD oil, gel caps, vaporizers and isolate have been on the market for a little while now. Common CBD oil relieves a range of health ailments. Utilizing these products could be very beneficial to fighters who are looking for alternatives to pharmaceuticals and pain management drugs.
Marijuana, however will still be banned by the WADA. Tests for marijuana typically look for THC, the main psychoactive component which gives you the feeling of being “high.” Luckily for CBD users, most products contain no THC whatsoever. This means athletes will not have to worry about passing a drug test when using CBD products. CBD oil also has no side-effects, perfect for those who don’t enjoy the psychoactive effects of marijuana.
The US Anti-Doping Agency will be updating their handbook in accordance with their new rules and have even more information available on their website, ufc.usada.org.
They FDA weighed in on CBD back in August stating:
“Cannabidiol (CBD) is one of the active cannabinoids identified in cannabis. CBD has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy. In the United States, CBD-containing products are in human clinical testing in three therapeutic areas, but no such products are approved by FDA for marketing for medical purposes in the United States. CBD is a Schedule I controlled substance under the CSA. At the 37th (2015) meeting of the ECDD, the committee requested that the Secretariat prepare relevant documentation to conduct pre-reviews for several substances, including CBD.”